Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-19 VAN BEEK JEROEN B Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2020-12-01 Miller Edward General Counsel Gift −41,514 166,051
2020-12-01 Miller Edward General Counsel Gift +41,514 198,811
2020-11-30 Leen Ann M. Chief Scientific Officer Gift −60,394 0
2020-11-30 Leen Ann M. Chief Scientific Officer Gift +60,394 60,394
2020-08-03 Vera Juan Director Conversion +2,436,773 2,466,970
2020-08-03 Vera Juan Director Conversion · Series A-3 Convertible Preferred Stock −3,631,293 0
2020-08-03 Wilson John Robert Director Conversion +3,184,758 3,214,955
2020-08-03 Wilson John Robert Director Conversion +2,347,999 5,562,954
2020-08-03 Wilson John Robert Director Conversion · Series A-3 Convertible Preferred Stock −4,745,943 0
2020-08-03 Wilson John Robert Director Conversion · Series A-3 Convertible Preferred Stock −3,499,001 0
2020-08-03 Bornstein Jeffrey S Director Conversion +20,583 20,583
2020-08-03 Bornstein Jeffrey S Director Conversion · Series B Preferred Convertible Stock −30,674 0
2020-08-03 Miller Edward General Counsel Conversion +32,759 32,759
2020-08-03 Miller Edward General Counsel Conversion · Series B Convertible Preferred Stock −48,819 0
2020-08-03 Leen Ann M. Chief Scientific Officer Conversion +2,436,773 2,436,773
2020-08-03 Leen Ann M. Chief Scientific Officer Conversion · Series A-3 Convertible Preferred Stock −3,631,293 0
2020-08-03 Jovan-Embiricos Morana Director Conversion +13,420,970 13,420,970
2020-08-03 Jovan-Embiricos Morana Director Conversion +247,011 247,011
2020-08-03 Jovan-Embiricos Morana Director Conversion +1,399,732 1,399,732

Page 26 of 27 · 527 trades